Skip to main content
Log in

Apparent extinction of non-G2 rotavirus strains from circulation in Recife, Brazil, after the introduction of rotavirus vaccine

  • Rapid Communication
  • Published:
Archives of Virology Aims and scope Submit manuscript

Abstract

The introduction of a G1P[8] rotavirus vaccine in Recife, Brazil, caused a decrease in rotavirus detection from 27% (March–May, 2006) to 5.0% (March–May, 2007), with all strains becoming G2, against which less protection had been predicted.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Araujo IT, Fialho AM, de Assis RM, M, Galvao M, Cruz CM, Ferreira MS, Leite JP (2002) Rotavirus strain diversity in Rio de Janeiro, Brazil: characterization of VP4 and VP7 genotypes in hospitalized children. J Trop Pediatr 48:214–218

    Article  PubMed  Google Scholar 

  2. Bok K, Castagnaro N, Borsa A, Nates S, Espul C, Fay O, Fabri A, Grinstein S, Miceli I, Matson DO, Gomez JA (2001) Surveillance for rotavirus in Argentina. J Med Virol 65:190–198

    Article  PubMed  CAS  Google Scholar 

  3. Castello A, Arvay M, Glass R, Gentsch J (2004) Rotavirus strain surveillance in Latin America: a review of the last nine years. Pediatr Infect Dis J 23(suppl):168–172

    Article  Google Scholar 

  4. Cunliffe NA, Nakagomi O (2005) A critical time for rotavirus vaccines: a review. Expert Rev Vaccines 4:521–532

    Article  PubMed  CAS  Google Scholar 

  5. Estes MK, Kapikian AZ (2007) Rotavirus. In: Knipe DM, Howley PM (eds) Fields virology. 5th edn. vol 2. Lippincott Williams and Wilkins, Philadelphia, pp 1917–1974

    Google Scholar 

  6. Gentsch JR, Glass RI, Woods P, Gouvea V, Gorziglia M, Flores J, Das BK, Bhan MK (1992) Identification of group A rotavirus gene 4 types by polymerase chain reaction. J Clin Microbiol 30:1365–1373

    PubMed  CAS  Google Scholar 

  7. Gouvea V, Glass RI, Woods P, Taniguchi K, Clark HF, Forreter B, Fang ZY (1990) Polymerase chain reaction amplification and typing of rotavirus nucleic acids from stool specimens. J Clin Microbiol 28:276–282

    PubMed  CAS  Google Scholar 

  8. Kapikian AZ, Hoshino Y (2007) To serotype or not to serotype: that is still the question. J Infect Dis 195:625–632

    Article  Google Scholar 

  9. Kutsuzawa T, Konno T, Suzuki H, Kapikian AZ, Ebina T, Ishida N (1982) Isolation of human rotavirus subgroups 1 and 2 in cell culture. J Clin Microbiol 16:727–730

    PubMed  CAS  Google Scholar 

  10. Montenegro FM, Correia JB, Falbo AR, Dove W, Nakagomi T, Nakagomi O, Cuevas LE, Cunliffe NA, Hart CA (2007) Anticipating rotavirus vaccines in Brazil: detection and molecular characterization of emerging rotavirus serotypes G8 and G9 among children with diarrhea in Recife, Brazil. J Med Virol 79:335–340

    Article  PubMed  Google Scholar 

  11. Parashar UE, Gibson CJ, Bresee J, Glass R (2006) Rotavirus and severe childhood diarrhea. Emerg Infect Dis 12:304–306

    PubMed  Google Scholar 

  12. PATH’s Rotavirus Vaccine Program (2006) Accelerating the introduction of rotavirus vaccines into GAVI-eligible countries. http://www.gavialliance.org/resources/Rotavirus_Investment_Case_Oct06.pdf. Accessed 10 Oct 2007

  13. Ruiz-Palacios GM, Perez-Schael I, Velazquez FR, Abate H, Breuer T, Clemens SC, Cheuvart B, Espinoza F, Gillard P, Innis BL, Cervantes Y, Linhares AC, Lopez P, Macias-Parra M, Ortega-Barria E, Richardson V, Rivera-Medina DM, Rivera L, Salinas B, Pavia-Ruz N, Salmeron J, Ruttimann R, Tinoco JC, Rubio P, Nunez E, Guerrero ML, Yarzabal JP, Damaso S, Tornieporth N, Saez-Llorens X, Vergara RF, Vesikari T, Bouckenooghe A, Clemens R, De Vos B, O’Ryan M; Human Rotavirus Vaccine Study Group (2006) Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med 354:11–22

    Article  PubMed  CAS  Google Scholar 

  14. Vesikari T, Matson DO, Dennehy P, Van Damme P, Santosham M, Rodriguez Z, Dallas MJ, Heyse JF, Goveia MG, Black SB, Shinefield HR, Christie CD, Ylitalo S, Itzler RF, Coia ML, Onorato MT, Adeyi BA, Marshall GS, Gothefors L, Campens D, Karvonen A, Watt JP, O’Brien KL, DiNubile MJ, Clark HF, Boslego JW, Offit PA, Heaton PM; Rotavirus Efficacy, Safety Trial (REST) Study Team (2006) Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med 354:23–33

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

T. Nakagomi was supported by a grant-in-aid for general scientific research by the Japan Society for Promotion of Sciences (No. 18406016). Both T. Nakagomi and O. Nakagomi are honorary members of the Department of Medical Microbiology, the University of Liverpool, and they conducted this research in accordance with the agreement on academic partnership between Nagasaki University and the University of Liverpool.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to T. Nakagomi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nakagomi, T., Cuevas, L.E., Gurgel, R.G. et al. Apparent extinction of non-G2 rotavirus strains from circulation in Recife, Brazil, after the introduction of rotavirus vaccine. Arch Virol 153, 591–593 (2008). https://doi.org/10.1007/s00705-007-0028-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00705-007-0028-z

Keywords

Navigation